Evidence map›Paper›PMID 28851056›Full record

ArticleJournal of medical virology2018

Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers.

Diana Vilar-Compte, Dimpy P Shah, Jakapat Vanichanan, Patricia Cornejo-Juarez, Alejandro Garcia-Horton, Patricia Volkow, Roy F Chemaly

Open access · greenAbstract read
In one paragraph

Article in Journal of medical virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Guideline
  2. Corticosteroids as adjunctive therapy in the treatment of influenza.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Viral Respiratory Infections in Hematological Patients.Infectious diseases and therapy · 2020
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Burden of Seasonal Human Coronavirus Infections in Hematopoietic Cell Transplant Recipients.Transplant infectious disease : an official journal of the Transplantation Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Diana Vilar-CompteDepartment of Infectious Diseases, Instituto Nacional de Cancerología, Mexico City, Mexico.
Dimpy P ShahDepartment of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Cancer Center, Houston, Texas.
Jakapat VanichananDepartment of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Cancer Center, Houston, Texas.
Patricia Cornejo-JuarezDepartment of Infectious Diseases, Instituto Nacional de Cancerología, Mexico City, Mexico.
Alejandro Garcia-HortonDepartment of Infectious Diseases, Instituto Nacional de Cancerología, Mexico City, Mexico.
Patricia VolkowDepartment of Infectious Diseases, Instituto Nacional de Cancerología, Mexico City, Mexico.
Roy F ChemalyDepartment of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Cancer Center, Houston, Texas.
Instituto Nacional de Cancerología · MXThe University of Texas MD Anderson Cancer Center · USWestern University · CA

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

The burden of influenza infections in patients with hematological malignancies (HMs) is not well defined. We describe the clinical presentation and associated outcomes of influenza at two comprehensive cancer centers (center 1 in the United States and center 2 in Mexico). Clinical and laboratory data on patients with HMs and influenza infection diagnosed from April 2009 to May 2014 at the two centers were reviewed retrospectively. A total of 190 patients were included, the majority were male (63%) with a median age of 49 years (range, 1-88 years), and had active or refractory HMs (76%). Compared to center 1, patients in center 2 were significantly sicker (active cancer, decreased albumin levels, elevated creatinine levels, or hypoxia at influenza diagnosis) and experienced higher lower respiratory tract infection (LRI) rate (42% vs 7%; P < 0.001). In multivariable logistic regression analysis (odds ratio, 95% confidence interval), leukemia, (3.09, 1.23-7.70), decreased albumin level (3.78, 1.55-9.20), hypoxia at diagnosis (14.98, 3.30-67.90), respiratory co-infection (5.87, 1.65-20.86), and corticosteroid use (2.71, 1.03-7.15) were significantly associated with LRI; and elevated creatinine level (3.33, 1.05-10.56), hypoxia at diagnosis (5.87, 1.12-30.77), and respiratory co-infection (6.30, 1.55-25.67) were significantly associated with 60 day mortality in both centers. HM patients with influenza are at high risk for serious complications such as LRI and death, especially if they are immunosuppressed. Patients with respiratory symptoms should seek prompt medical care during influenza season.

Indexed as

AdolescentAdultAgedAged, 80 and overAntiviral AgentsChildChild, PreschoolCoinfectionFemaleHematologic NeoplasmsHumansHypoxiaImmunocompromised HostInfantInfluenza, HumanLogistic ModelsAntiviral AgentsSerum AlbumincancerH1N1influenzaleukemialymphomamyelomapneumonia

Identifiers

PMID28851056
PMCPMC5761331
OpenAlexW2751910294

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.